Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
glutamic acid (Verla-Pharm)
- Development stage
- Unknown
- Lead developer
- Verla-Pharm
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Glutamin Verla is an over-the-counter (OTC) traditional medicine developed and marketed by Verla-Pharm in Germany. It is formulated as coated tablets containing 330 mg of glutamic acid (Glutaminsäure) per tablet. Glutamin Verla is traditionally used to improve general well-being and support mental fitness and cognitive function. Glutamic acid is an amino acid that serves as a key excitatory neurotransmitter and metabolic substrate in the central nervous system, playing a vital role in signal transmission, energy supply to brain cells, and the detoxification of ammonia.
- Brand names
- Glutamic-500Glutamic500Glutamic 500Glutamin Verla
- Other names
- GlutaminsäureL-glutamateL-glutamic acidglutamateglutamic acid
02
Targets
AMPAR (AMPA receptor)NMDAR (Glutamate receptor ionotropic, NMDA)Kainate-type ionotropic glutamate receptormGluR (Metabotropic glutamate receptors)
Beyond the preview
Go deeper on glutamic acid (Verla-Pharm).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on glutamic acid (Verla-Pharm).